• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效液相色谱法测定人血浆中的他莫司汀

Determination of tallimustine in human plasma by high-performance liquid chromatography.

作者信息

Marrari P, Pianezzola E, Strolin Benedetti M

机构信息

Pharmacia, Department of Pharmacokinetics and Metabolism, Milan, Italy.

出版信息

J Chromatogr B Biomed Appl. 1996 Feb 23;677(1):133-9. doi: 10.1016/0378-4347(95)00437-8.

DOI:10.1016/0378-4347(95)00437-8
PMID:8925085
Abstract

A sensitive and reproducible HPLC method for the determination of tallimustine (I) in human plasma has been developed and validated. Compound I was extracted from plasma by solid-phase extraction using a C18 cartridge from which the test compound was eluted with a methanol-formic acid mixture. The methanol solution was evaporated to dryness and the residue dissolved in a 0.2 M formic acid in methanol-water (1:1, v/v) mixture, then injected onto the HPLC column. The chromatographic separation was performed isocratically by a reversed-phase column filled with ODS, using a 50 mM KH2PO4-acetonitrile mixture as the mobile phase. The flow-rate was 1 ml/min. The eluate was monitored at 314 nm. No peak interfering with that of I was observed when blank human plasma was assayed. Linearity was established in the concentration range 0.5-85.5 nanograms of I per millilitre of plasma. Four calibration curves in plasma, prepared and run on four different days, showed correlation coefficients higher than 0.99 and good reproducibility of the slope (C.V. = 4.5%). The intra-day precision, evaluated at three concentrations (in the low, mid and high range of the standard curve) and expressed as C.V. ranged from 0.9 to 14.4%. The inter-day precision evaluated at the same concentrations was better than 10.2%. The inter-day accuracy evaluated in the same samples and expressed as the ratio of found/added amount of I, ranged from 86.2 to 108.5%. The limit of quantitation was 0.5 ng/ml plasma. The HPLC method described here was successfully employed for the determination of I in some plasma samples obtained during a phase I clinical trial with the test compound.

摘要

已开发并验证了一种灵敏且可重现的高效液相色谱法,用于测定人血浆中的他利莫司(I)。化合物I通过使用C18柱的固相萃取从血浆中提取,测试化合物用甲醇 - 甲酸混合物从柱上洗脱。将甲醇溶液蒸发至干,残余物溶解于甲醇 - 水(1:1,v/v)的0.2 M甲酸混合物中,然后注入高效液相色谱柱。色谱分离通过填充有ODS的反相柱等度进行,使用50 mM KH2PO4 - 乙腈混合物作为流动相。流速为1 ml/min。在314 nm处监测洗脱液。测定空白人血浆时未观察到干扰I峰的峰。在每毫升血浆中I的浓度范围为0.5 - 85.5纳克时建立了线性关系。在四个不同日期制备并运行的血浆中的四条校准曲线显示相关系数高于0.99,斜率具有良好的重现性(变异系数 = 4.5%)。日内精密度在三个浓度(标准曲线的低、中、高范围)下评估,以变异系数表示,范围为0.9%至14.4%。在相同浓度下评估的日间精密度优于10.2%。在相同样品中评估的日间准确度以I的测定值/添加量的比率表示,范围为86.2%至108.5%。定量限为0.5 ng/ml血浆。本文所述的高效液相色谱法已成功用于在一项使用测试化合物的I期临床试验期间获得的一些血浆样品中I的测定。

相似文献

1
Determination of tallimustine in human plasma by high-performance liquid chromatography.高效液相色谱法测定人血浆中的他莫司汀
J Chromatogr B Biomed Appl. 1996 Feb 23;677(1):133-9. doi: 10.1016/0378-4347(95)00437-8.
2
Determination of turosteride, a new inhibitor of 5 alpha-reductase, in human plasma by high-performance liquid chromatography with ultraviolet detection.
J Chromatogr B Biomed Sci Appl. 1997 Jan 10;688(1):117-25. doi: 10.1016/s0378-4347(97)88063-2.
3
Stereoselective determination of unchanged and glucuroconjugated eliprodil, a new anti-ischaemic drug, in human plasma and urine by precolumn derivatization and column-switching high-performance liquid chromatography with fluorescence detection.通过柱前衍生化和柱切换高效液相色谱-荧光检测法对新型抗缺血药物埃利罗地及其葡萄糖醛酸共轭物在人血浆和尿液中的立体选择性测定。
J Chromatogr A. 1996 Apr 5;729(1-2):323-33. doi: 10.1016/0021-9673(95)00893-4.
4
Automated and sensitive method for the determination of formoterol in human plasma by high-performance liquid chromatography and electrochemical detection.高效液相色谱法与电化学检测联用测定人血浆中福莫特罗的自动化灵敏方法。
J Chromatogr B Biomed Sci Appl. 1997 Dec 19;704(1-2):221-9. doi: 10.1016/s0378-4347(97)00425-8.
5
Development and validation of a high-performance liquid chromatographic method for the determination of methocarbamol in human plasma.一种用于测定人血浆中甲氯卡胺的高效液相色谱法的开发与验证。
J Chromatogr B Biomed Appl. 1994 Apr 1;654(2):287-92. doi: 10.1016/0378-4347(94)00010-7.
6
Determination of ABT-089 in human plasma by high performance liquid chromatography using in situ precolumn derivatization with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole.采用7-氟-4-硝基苯并-2-恶唑-1,3-二氮唑原位柱前衍生化高效液相色谱法测定人血浆中的ABT-089。
J Pharm Biomed Anal. 1999 Jun;20(1-2):49-63. doi: 10.1016/s0731-7085(98)00301-x.
7
Determination of olanzapine in human breast milk by high-performance liquid chromatography with electrochemical detection.高效液相色谱-电化学检测法测定人母乳中的奥氮平。
J Chromatogr B Biomed Sci Appl. 1999 Apr 16;726(1-2):203-9. doi: 10.1016/s0378-4347(99)00017-1.
8
High-performance liquid chromatographic-ultraviolet assay for the simultaneous quantitation of BMS-181101 and its putative hydroxy metabolites in rat and monkey plasma.高效液相色谱 - 紫外检测法同时定量大鼠和猴血浆中的BMS - 181101及其假定的羟基代谢物。
Biomed Chromatogr. 1996 May-Jun;10(3):135-8. doi: 10.1002/(SICI)1099-0801(199605)10:3<135::AID-BMC575>3.0.CO;2-B.
9
Determination of piroximone in human plasma by high-performance liquid chromatography.高效液相色谱法测定人血浆中的吡罗昔酮
Ther Drug Monit. 1994 Oct;16(5):499-503. doi: 10.1097/00007691-199410000-00010.
10
High-performance liquid chromatographic determination of modafinil and its two metabolites in human plasma using solid-phase extraction.使用固相萃取法通过高效液相色谱法测定人体血浆中的莫达非尼及其两种代谢物。
J Chromatogr B Biomed Sci Appl. 1998 Mar 20;706(2):295-304. doi: 10.1016/s0378-4347(97)00550-1.